Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload

Peng Yue,Yue Zhang,Lei Liu,Kaiyu Zhou,Shutao Xia,Mou Peng,Hualin Yan,Xiaoqiang Tang,Zhan Chen,Donghui Zhang,Junling Guo,William T. Pu,Yuxuan Guo,Yimin Hua,Yifei Li

DOI: https://doi.org/10.7150/thno.74563

IF: 11.6

2022-01-01

Theranostics

Abstract:Rationale: Chronic pressure overload is a major trigger of cardiac pathological hypertrophy that eventually leads to heart disease and heart failure. Understanding the mechanisms governing hypertrophy is the key to develop therapeutic strategies for heart diseases. Methods: We built chronic pressure overload mice model by abdominal aortic constriction (AAC) to explore the features of Yes-associated protein 1 (YAP1). Then AAV-cTNT-Cre was applied to Yap1F/F mice to induce mosaic depletion of YAP1. Myh6CreERT2; H11CAG-LSL-YAP1 mice were involved to establish YAP1 overexpression model by Tomaxifen injection. ATAC-seq and bioChIP-seq were used to explore the potential targets of YAP1, which were verified by a series of luciferase reporter assays. Dnm1l and Mfn1 were re-expressed in AAC mice by AAV-cTNT-Dnm1l and AAV-cTNT-Mfn1. Finally, Verteprofin was used to inhibit YAP1 to rescue cardiac hypertrophy. Results: We found that pathological hypertrophy was accompanied with the activation of YAP1. Cardiomyocyte-specific deletion of Yap1 attenuated AAC-induced hypertrophy. Overexpression of YAP1 was sufficient to phenocopy AAC-induced hypertrophy. YAP1 activation resulted in the perturbation of mitochondria ultrastructure and function, which was associated with the repression of mitochondria dynamics regulators Dnm1l and Mfn1. Mitochondrial-related genes Dnm1l and Mfn1, are significantly targeted by TEAD1/YAP complex. Overexpression of Dnm1l and Mfn1 synergistically rescued YAP1-induced mitochondrial damages and cardiac hypertrophy. Pharmacological repression of YAP1 by verteporfin attenuated mitochondrial damages and pathological hypertrophy in AAC-treated mice. Interestingly, YAP1-induced mitochondria damages also led to increased reactive oxidative species, DNA damages, and the suppression of cardiomyocyte proliferation. Conclusion: Together, these data uncovered YAP signaling as a therapeutic target for pressure overload-induced heart diseases and cautioned the efforts to induce cardiomyocyte regeneration by activating YAP.

medicine, research & experimental

What problem does this paper attempt to address?

This paper aims to explore the regulatory role and mechanism of YAP1 in cardiomyocyte hypertrophy under the condition of chronic mechanical stress overload. Specifically, by constructing a mouse model of chronic pressure overload, the researchers explored the function of YAP1 in the process of cardiomyocyte hypertrophy and found that the activation of YAP1 is related to impaired mitochondrial biogenesis. In addition, the study also revealed that YAP1 inhibits the expression of mitochondrial dynamics regulators Dnm1l and Mfn1, leading to mitochondrial structure and function disorders, thereby promoting pathological hypertrophy. These findings provide a new perspective for understanding the pathogenesis of heart diseases and potential targets for developing strategies to treat heart diseases. In short, the problems that this paper attempts to solve are: - **How does YAP1 affect cardiomyocyte hypertrophy under the condition of chronic mechanical stress overload?** - **Does the activation of YAP1 lead to mitochondrial dysfunction and then promote the pathological hypertrophy of cardiomyocytes?** - **What specific molecular mechanisms does YAP1 use to affect mitochondrial dynamics and function?** The answers to these questions are of great significance for understanding the development mechanism of heart diseases and developing new treatment methods.

Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload

Inhibition of TRPC1 Prevents Cardiac Hypertrophy Via NF-κB Signaling Pathway in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Abstract P2049: Myofibroblast Depletion of Yap and Wwtr1 Improves Cardiac Function after Myocardial Infarction Via Ccn3 Suppression

Abstract P3065: Myeloid YAP Inhibition Improves Cardiac Phenotype During Pressure Overload Stress

YAP dysregulation triggers hypertrophy by CCN2 secretion and TGFβ uptake in human pluripotent stem cell-derived cardiomyocytes

Abstract P480: Myeloid YAP Inhibition Improves Cardiac Phenotype During Pressure Overload Stress

Yap1, the Nuclear Target of Hippo Signaling, Stimulates Heart Growth Through Cardiomyocyte Proliferation but Not Hypertrophy

YAP Activation Promotes the Transdifferentiation of Cardiac Fibroblasts to Myofibroblasts in Matrix Remodeling of Dilated Cardiomyopathy

The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy

Myofibroblast Ccn3 is Regulated by Yap and Wwtr1 and Contributes to Adverse Cardiac Outcomes

YAP1 Contributes to The Development of Contractile Force and Sarcomere Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes

Abstract P3091: Suppression Of Myeloid Yap Antagonizes Adverse Cardiac Remodeling During Pressure Overload Stress

Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model

Yap overexpression attenuates septic cardiomyopathy by inhibiting DRP1-related mitochondrial fission and activating the ERK signaling pathway.

Targeting E3 Ubiquitin-Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination

Matrix Stiffness Controls Cardiac Fibroblast Activation Through Regulating YAP Via AT1 R.

AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis

An updated review of YAP: A promising therapeutic target against cardiac aging?

YAP/TAZ Deficiency Reprograms Macrophage Phenotype and Improves Infarct Healing and Cardiac Function after Myocardial Infarction

Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling

Novel Role of Mitochondrial GTPases 1 in Pathological Cardiac Hypertrophy